Bladder (advanced) Cancer Bladder
Conditions
Interventions
1. Schedule A: Radiotherapy, an accelerated fractionation schedule of 60.8 Gy given in thirty-two fractions over 26 days. Radiotherapy is given twice daily (morning dose of 1.8 Gy and 2.0 Gy in the af
Sponsors
The Institute of Cancer Research (UK)
Eligibility
Inclusion criteria
Inclusion criteria: 1. Stage T2 or T3 NXMO carcinoma of the bladder defined either by clinical findings or by histopathology 2. If nodes are assessed N1 patients (single node <2 cm) are eligible, N2 and N3 patients are excluded 3. Patients with severe concurrent general medical illness especially those with inflammatory bowel disease, other malignancies (except skin cancer), recent myocardial infarction (within 3 months) or previous major pelvic surgery are excluded
Exclusion criteria
Exclusion criteria: Not provided at time of registration
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Not provided at time of registration | — |
Secondary
| Measure | Time frame |
|---|---|
| Not provided at time of registration | — |
Countries
United Kingdom
Outcome results
None listed